AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site E119G
Virus Influenzavirus A H1N1
Mutation level Amino acid Level
Gene/protein/region type NA
Gene ID 23308118
Country Denmark
Mutation type nonsynonymous mutation
Genotype/subtype/clade -
Sample Human
Variants -
Viral reference sequence NC_026434.1
Drug/antibody/vaccine -
Transmissibility -
Transmission mechanism -
Pathogenicity -
Pathogenicity mechanism -
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name Neuraminidase
Uniprot protein ID C3W6G3
Protein length 469 amino acids
Protein description The NA assembles as a tetramer of four identical polypeptides and, when embedded in the envelope of the virus, accounts for approximately 10-20% of the total glycoproteins on the virion surface, with about 40-50 NA spikes and 300-400 HA spikes on an average sized virion of 120 nm. The four monomers, each of approximately 470 amino acids, fold into four distinct structural domains: the cytoplasmic tail, the transmembrane region, the stalk, and the catalytic head. The NA catalyzes the removal of terminal sialic acid residues from viral and cellular glycoconjugates. Cleaves off the terminal sialic acids on the glycosylated HA during virus budding to facilitate virus release. Additionally helps virus spread through the circulation by further removing sialic acids from the cell surface. These cleavages prevent self-aggregation and ensure the efficient spread of the progeny virus from cell to cell. Otherwise, infection would be limited to one round of replication. Described as a receptor-destroying enzyme because it cleaves a terminal sialic acid from the cellular receptors. May facilitate viral invasion of the upper airways by cleaving the sialic acid moities on the mucin of the airway epithelial cells.

Literature information:


Pubmed ID 28128091
Clinical information No
Disease -
Published year 2017
Journal Euro Surveill
Title Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2016
Author Ramona Trebbien,Svend Stenvang Pedersen,Kristine Vorborg,Kristina Træholt Franck,Thea Kølsen Fischer
Evidence H275Y(65.1%), I223R(9.2%), and E119G(89.7%), accompanied by additional mutations, showing a more complex viral population in the long-term treated patient.